Skip to main content
HairCited

Minoxidil के लिए महिला पैटर्न बाल झड़ना

A

67 अध्ययनों (4 meta-analyses, 11 RCTs) पर आधारित, में कुल 28,815 प्रतिभागियों के साथ। 53/67 अध्ययन सकारात्मक प्रभाव दिखाते हैं।

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

निष्कर्ष

Research strongly suggests that minoxidil may help women with female pattern hair loss regain hair density, supported by numerous high-quality clinical trials.

  • 67 studies including 11 RCTs and 4 meta-analyses specifically in women
  • 79% of studies report positive effects on hair growth
  • Low-dose oral minoxidil is emerging as a well-tolerated alternative to topical application
  • Combination with other ingredients like spironolactone may enhance results

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: women with androgenetic alopecia (female pattern hair loss)

Other
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern …
Dose: MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day बनाम: None Outcome: consensus recommendations for managing pattern hair loss प्रभाव: None None

जनसंख्या: hair transplant patients with male and female pattern hair loss (Delphi panel consensus)

review
Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current …
Dose: varies by agent and study बनाम: Placebo प्रभाव: variable; oral antiandrogens demonstrate some efficacy; topical antiandrogens possibly fewer systemi None
narrative review
Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions.
Dose: None बनाम: Placebo प्रभाव: None None
randomized controlled trial n=45 16 weeks Open-label
Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in …
Dose: Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi बनाम: Placebo प्रभाव: Groups A and C showed significant improvement on Sinclair scale and trichoscopic hair density; Group None
Review
Male and female pattern hair loss.
Dose: None बनाम: Placebo प्रभाव: None None

Key Statistics

111

अध्ययन

37800

प्रतिभागी

Positive

A

ग्रेड

Referenced Papers

Australian prescriber 2025 2 उद्धरण
Annals of dermatology 2025
SAGE open medical … 2024 3 उद्धरण
Drugs 2023 221 उद्धरण
Anais brasileiros de … 2023 29 उद्धरण
Skin appendage disorders 2023 7 उद्धरण
Journal of cosmetic … 2023 3 उद्धरण
The Journal of … 2022 170 उद्धरण
Faculty reviews 2022 44 उद्धरण
Journal of cosmetic … 2022 7 उद्धरण
Journal of the … 2021 42 उद्धरण
American journal of … 2020 127 उद्धरण
International journal of … 2020 58 उद्धरण
Indian dermatology online … 2020 31 उद्धरण
Journal of cosmetic … 2019 34 उद्धरण
Actas dermo-sifiliograficas 2019 5 उद्धरण
International journal of … 2018 129 उद्धरण
Australian journal of … 2018 8 उद्धरण
JAMA dermatology 2017 121 उद्धरण
The Cochrane database … 2016 18 उद्धरण
The Medical clinics … 2015 66 उद्धरण
World journal of … 2015 62 उद्धरण
Seminars in cutaneous … 2015 27 उद्धरण
Seminars in cutaneous … 2015 20 उद्धरण
Clinical obstetrics and … 2015 9 उद्धरण
Current problems in … 2015 8 उद्धरण
Skin therapy letter 2014 29 उद्धरण
Journal of drugs … 2014 26 उद्धरण
Dermatologic clinics 2013 78 उद्धरण
International journal of … 2013 61 उद्धरण
Indian journal of … 2013 16 उद्धरण
International journal of … 2013
The British journal … 2012 48 उद्धरण
The Cochrane database … 2012 15 उद्धरण
Skinmed 2012 5 उद्धरण
The British journal … 2011 96 उद्धरण
The Australasian journal … 2011 44 उद्धरण
Indian journal of … 2009 109 उद्धरण
Seminars in cutaneous … 2009 4 उद्धरण
American family physician 2009
Journal of the … 2008 290 उद्धरण
The Australasian journal … 2007 32 उद्धरण
Clinical interventions in … 2007
Duodecim; laaketieteellinen aikakauskirja 2006
Journal of the … 2005 247 उद्धरण
The British journal … 2005 205 उद्धरण
The journal of … 2003 102 उद्धरण
Clinical and experimental … 2002 61 उद्धरण
Therapeutische Umschau. Revue … 2002 4 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

topical:
2-5% solution, twice daily

अधिकतम सीमा: 5% topical solution

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None -- Neutral --
MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day -- Positive --
varies by agent and study -- Positive --
None -- Positive --
Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi 16 weeks Positive 45
None -- Positive --
Spironolactone 100 mg once daily 24 weeks Positive 48
None -- Positive --

सेवन का सर्वोत्तम समय: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

ज्ञात अंतःक्रियाएँ

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

सहनीय अधिकतम सेवन: 5% topical solution

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Minoxidil help with महिला पैटर्न बाल झड़ना?
Based on 111 studies with 37,800 participants, there is strong evidence from multiple clinical trials that Minoxidil may support महिला पैटर्न बाल झड़ना management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for महिला पैटर्न बाल झड़ना?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and महिला पैटर्न बाल झड़ना?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 111 peer-reviewed studies with 37,800 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री महिला पैटर्न बाल झड़ना

Minoxidil अन्य स्वास्थ्य स्थितियों के लिए

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।